| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1996 Oxford University Press
research-article |
Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3
1Department of Molecular Biology, Parke-Davis Pharmaceutical Research, A Division of Warner-Lamber Company Ann Arbor, MI 48105
2Biological Carcinogenesis and Development Program SAIC-Frederick
3Cell Biology Section, Laboratory of Viral Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center Frederick, MD 21702
4Department of Biochemistry and Molecular Biology, Georgetown University Washington DC
5Laboratory of Biochemical Physiology, Division of Basic Science NCI-FCRDC, Frederick, MD, USA
6To whom correspondence should be addressed at: Department of Molecular Biology, Parke-Davis Pharmaceutical Research, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
Tissue inhibitor of metalloproteinases-3(TEMP-3), a novel member of TEMP family genes, has been recently cloned and shown to be expressed in preneoplastic but not in neoplastic mouse JB6 epidermal cells (Sun et al. 1994 Cancer Res., 54, 11139). This down regulation of the gene appears to be attributable at least in part to alteration of gene methylation (Sun et al. 1995 J. Biol Chem., 270, 19312). Little is known, however, about the role of TEMP-3 in human cancers. We screened several human tumor cell lines for TEMP-3 expression and found that a colon carcinoma line, DLD-1, did not express TEMP-3. If down regulation of TIMP-3 is causally related to carcino-genesis, re-expression by transfection may reverse the tumor cell phenotype. We therefore overexpressed human TEMP-3 in DLD-1 cells. TEMP-3 transfectants showed a serum-dependent growth inhibition in monolayer culture and a decreased growth potential in nude mice in a manner dependent on the level of TEMP-3 expression. A transfectant expressing a high level of active hTEMP-3 completely lost the ability to form tumors following s.c. injection into nude mice. We also tested TEMP-3 expressing cells and neocontrol TEMP-3 negative cells for their ability to grow in liquid suspension culture, since both cells grew in semi-solid soft agar. As compared to neocontrol cells, TIMP-3 over-expressors formed large aggregates, followed by cell death. This effect was not mimicked by BB94, a broad MMP inhibitor. We conclude from this study that (i) TEMP-3 overexpression in human colon carcinoma cells induces growth arrest in low serum conditions and inhibits in vivo tumor growth and (ii) the TEMP-3-induced large aggregate formation and subsequent cell death under suspension growth cannot be explained by its MMP inhibitory activity.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Waldhauer, D. Goehlsdorf, F. Gieseke, T. Weinschenk, M. Wittenbrink, A. Ludwig, S. Stevanovic, H.-G. Rammensee, and A. Steinle Tumor-Associated MICA Is Shed by ADAM Proteases Cancer Res., August 1, 2008; 68(15): 6368 - 6376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Stetler-Stevenson Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities Sci. Signal., July 8, 2008; 1(27): re6 - re6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M A Majid, V A Smith, F J Matthews, A C Newby, and A D Dick Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane Br J Ophthalmol, October 1, 2006; 90(10): 1310 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L.M. Lamfers, D. Gianni, C.-H. Tung, S. Idema, F. H.E. Schagen, J. E. Carette, P. H.A. Quax, V. W. Van Beusechem, W. P. Vandertop, C. M.F. Dirven, et al. Tissue Inhibitor of Metalloproteinase-3 Expression from an Oncolytic Adenovirus Inhibits Matrix Metalloproteinase Activity In vivo without Affecting Antitumor Efficacy in Malignant Glioma Cancer Res., October 15, 2005; 65(20): 9398 - 9405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-W. Liu, M. E. Taube, K.-K. Jung, Z. Dong, Y. J. Lee, S. Roshy, B. F. Sloane, R. Fridman, and H.-R. C. Kim Tissue Inhibitor of Metalloproteinase-1 Protects Human Breast Epithelial Cells from Extrinsic Cell Death: A Potential Oncogenic Activity of Tissue Inhibitor of Metalloproteinase-1 Cancer Res., February 1, 2005; 65(3): 898 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-C. Xue, K. Y.K. Chan, H.-C. Feng, P.-M. Chiu, H. Y.S. Ngan, S.-W. Tsao, and A. N.Y. Cheung Promoter Hypermethylation of Multiple Genes in Hydatidiform Mole and Choriocarcinoma J. Mol. Diagn., November 1, 2004; 6(4): 326 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. S. Dhillon, M. Aslam, and S. A. Husain The Contribution of Genetic and Epigenetic Changes in Granulosa Cell Tumors of Ovarian Origin Clin. Cancer Res., August 15, 2004; 10(16): 5537 - 5545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Takahashi, N. Shivapurkar, J. Reddy, H. Shigematsu, K. Miyajima, M. Suzuki, S. Toyooka, S. Zochbauer-Muller, J. Drach, G. Parikh, et al. DNA Methylation Profiles of Lymphoid and Hematopoietic Malignancies Clin. Cancer Res., May 1, 2004; 10(9): 2928 - 2935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-W. Liu, M. M. Bernardo, R. Fridman, and H.-R. C. Kim Tissue Inhibitor of Metalloproteinase-1 Protects Human Breast Epithelial Cells Against Intrinsic Apoptotic Cell Death via the Focal Adhesion Kinase/Phosphatidylinositol 3-Kinase and MAPK Signaling Pathway J. Biol. Chem., October 10, 2003; 278(41): 40364 - 40372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wild, A. Ramaswamy, P. Langer, I. Celik, V. Fendrich, B. Chaloupka, B. Simon, and D. K. Bartsch Frequent Methylation-Associated Silencing of the Tissue Inhibitor of Metalloproteinase-3 Gene in Pancreatic Endocrine Tumors J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1367 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. Spurbeck, C. Y. C. Ng, T. S. Strom, E. F. Vanin, and A. M. Davidoff Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model Blood, October 16, 2002; 100(9): 3361 - 3368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Baker, D. R. Edwards, and G. Murphy Metalloproteinase inhibitors: biological actions and therapeutic opportunities J. Cell Sci., January 10, 2002; 115(19): 3719 - 3727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. LEGALLICIER, G. TRUGNAN, G. MURPHY, B. LELONGT, P. RONCO, and P. FONTANGES Expression of the Type IV Collagenase System during Mouse Kidney Development and Tubule Segmentation J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2358 - 2369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yan and M. A. Moses A Case of Tumor Betrayal : Biphasic Effects of TIMP-1 on Burkitt's Lymphoma Am. J. Pathol., April 1, 2001; 158(4): 1185 - 1190. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hidalgo and S. G. Eckhardt Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy J Natl Cancer Inst, February 7, 2001; 93(3): 178 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zöchbauer-Müller, K. M. Fong, A. K. Virmani, J. Geradts, A. F. Gazdar, and J. D. Minna Aberrant Promoter Methylation of Multiple Genes in Non-Small Cell Lung Cancers Cancer Res., January 1, 2001; 61(1): 249 - 255. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z. Yang, T. R. Kyriakides, and P. Bornstein Matricellular Proteins as Modulators of Cell-Matrix Interactions: Adhesive Defect in Thrombospondin 2-null Fibroblasts is a Consequence of Increased Levels of Matrix Metalloproteinase-2 Mol. Biol. Cell, October 1, 2000; 11(10): 3353 - 3364. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. WESTERMARCK and V.-M. KÄHÄRI Regulation of matrix metalloproteinase expression in tumor invasion FASEB J, May 1, 1999; 13(8): 781 - 792. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. D. Pennie, G. A. Hegamyer, M. R. Young, and N. H. Colburn Specific Methylation Events Contribute to the Transcriptional Repression of the Mouse Tissue Inhibitor of Metalloproteinases-3 Gene in Neoplastic Cells Cell Growth Differ., April 1, 1999; 10(4): 279 - 286. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Y. Li, C. F. McTiernan, and A. M. Feldman Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells Cardiovasc Res, April 1, 1999; 42(1): 162 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Bachman, J. G. Herman, P. G. Corn, A. Merlo, J. F. Costello, W. K. Cavenee, S. B. Baylin, and J. R. Graff Methylation-associated Silencing of the Tissue Inhibitor of Metalloproteinase-3 Gene Suggests a Suppressor Role in Kidney, Brain, and Other Human Cancers Cancer Res., February 1, 1999; 59(4): 798 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Cox, W P Steward, and K J O'Byrne The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer Thorax, February 1, 1999; 54(2): 169 - 179. [Full Text]
|
|
|
|
 |
|
 W. Q. Liand and M. Zafarullah Oncostatin M Up-Regulates Tissue Inhibitor of Metalloproteinases-3 Gene Expression in Articular Chondrocytes via De Novo Transcription, Protein Synthesis, and Tyrosine Kinase- and Mitogen-Activated Protein Kinase-Dependent Mechanisms J. Immunol., November 1, 1998; 161(9): 5000 - 5007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Andreu, T. Beckers, E. Thoenes, P. Hilgard, and H. von Melchner Gene Trapping Identifies Inhibitors of Oncogenic Transformation. THE TISSUE INHIBITOR OF METALLOPROTEINASES-3 (TIMP3) AND COLLAGEN TYPE I alpha 2 (COL1A2) ARE EPIDERMAL GROWTH FACTOR-REGULATED GROWTH REPRESSORS J. Biol. Chem., May 29, 1998; 273(22): 13848 - 13854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Airola, M. Ahonen, N. Johansson, P. Heikkilä, J. Kere, V.-M. Kähäri, and U. K. Saarialho–Kere Human TIMP-3 Is Expressed During Fetal Development, Hair Growth Cycle, and Cancer Progression J. Histochem. Cytochem., April 1, 1998; 46(4): 437 - 448. [Abstract] [Full Text]
|
|